von Kleist M - Search Results

1

Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses.

Rath B, von Kleist M, Tief F, Karsch K, Tuerk E, Muehlhans S, Louis F, Skopnik H, Schweiger B, Duwe S. Rath B, et al. Among authors: von kleist m. Pediatr Infect Dis J. 2012 Sep;31(9):899-905. doi: 10.1097/INF.0b013e31825c7304. Pediatr Infect Dis J. 2012. PMID: 22581220

2

Antiviral resistance and correlates of virologic failure in the first cohort of HIV-infected children gaining access to structured antiretroviral therapy in Lima, Peru: a cross-sectional analysis.

Rath BA, von Kleist M, Castillo ME, Kolevic L, Caballero P, Soto-Castellares G, Amedee AM, Robinson JE, Katzenstein DK, Van Dyke RB, Oberhelman RA. Rath BA, et al. Among authors: von kleist m. BMC Infect Dis. 2013 Jan 2;13:1. doi: 10.1186/1471-2334-13-1. BMC Infect Dis. 2013. PMID: 23280237 Free PMC article.

3

In vitro HIV-1 evolution in response to triple reverse transcriptase inhibitors & in silico phenotypic analysis.

Rath BA, Yousef KP, Katzenstein DK, Shafer RW, Schütte C, von Kleist M, Merigan TC. Rath BA, et al. Among authors: von kleist m. PLoS One. 2013 Apr 17;8(4):e61102. doi: 10.1371/journal.pone.0061102. Print 2013. PLoS One. 2013. PMID: 23613794 Free PMC article.

4

Towards a personalised approach to managing influenza infections in infants and children - food for thought and a note on oseltamivir.

Rath B, Tief F, Karsch K, Muehlhans S, Obermeier P, Adamou E, Chen X, Seeber L, Peiser C, Hoppe C, von Kleist M, Conrad T, Schweiger B. Rath B, et al. Among authors: von kleist m. Infect Disord Drug Targets. 2013 Feb;13(1):25-33. doi: 10.2174/18715265112129990005. Infect Disord Drug Targets. 2013. PMID: 23675924

5

Quantitative influenza follow-up testing (QIFT)--a novel biomarker for the monitoring of disease activity at the point-of-care.

Chen X, Pouran Yousef K, Duwe S, Karsch K, Grover S, Wählisch S, Obermeier P, Tief F, Mühlhans S, Seeber L, von Kleist M, Schweiger B, Rath B. Chen X, et al. Among authors: von kleist m. PLoS One. 2014 Mar 21;9(3):e92500. doi: 10.1371/journal.pone.0092500. eCollection 2014. PLoS One. 2014. PMID: 24658130 Free PMC article.

6

Awareness and utilization of reporting pathways for adverse events following immunization: online survey among pediatricians in Russia and Germany.

Muehlhans S, von Kleist M, Gretchukha T, Terhardt M, Fegeler U, Maurer W, Namazova-Baranova L, Gaedicke G, Baranov A, Rath B. Muehlhans S, et al. Among authors: von kleist m. Paediatr Drugs. 2014 Aug;16(4):321-30. doi: 10.1007/s40272-014-0075-3. Paediatr Drugs. 2014. PMID: 24849291

7

Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: Analysis of national surveillance data.

Oh DY, Buda S, Biere B, Reiche J, Schlosser F, Duwe S, Wedde M, von Kleist M, Mielke M, Wolff T, Dürrwald R. Oh DY, et al. Among authors: von kleist m. Lancet Reg Health Eur. 2021 Jul;6:100112. doi: 10.1016/j.lanepe.2021.100112. Epub 2021 Jun 7. Lancet Reg Health Eur. 2021. PMID: 34124707 Free PMC article.

8

HIV quasispecies dynamics during pro-active treatment switching: impact on multi-drug resistance and resistance archiving in latent reservoirs.

von Kleist M, Menz S, Stocker H, Arasteh K, Schütte C, Huisinga W. von Kleist M, et al. PLoS One. 2011 Mar 24;6(3):e18204. doi: 10.1371/journal.pone.0018204. PLoS One. 2011. PMID: 21455303 Free PMC article.

9

Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection.

Duwal S, Schütte C, von Kleist M. Duwal S, et al. Among authors: von kleist m. PLoS One. 2012;7(7):e40382. doi: 10.1371/journal.pone.0040382. Epub 2012 Jul 11. PLoS One. 2012. PMID: 22808148 Free PMC article.

10

Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes.

Frank M, von Kleist M, Kunz A, Harms G, Schütte C, Kloft C. Frank M, et al. Among authors: von kleist m. Antimicrob Agents Chemother. 2011 Dec;55(12):5529-40. doi: 10.1128/AAC.00741-11. Epub 2011 Sep 26. Antimicrob Agents Chemother. 2011. PMID: 21947390 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page